Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$40 million in Series A funding. Ark’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. This record-breaking Series A round was led by...
